Home/Filings/4/0001600620-24-000028
4//SEC Filing

Knappertz Volker 4

Accession 0001600620-24-000028

CIK 0001600620other

Filed

Feb 28, 7:00 PM ET

Accepted

Feb 29, 4:11 PM ET

Size

4.5 KB

Accession

0001600620-24-000028

Insider Transaction Report

Form 4
Period: 2024-02-27
Knappertz Volker
EVP, Research and Development
Transactions
  • Sale

    Common Stock

    2024-02-27$6.10/sh4,930$30,073319,128 total

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1
  • filerCIK 0001754122

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 4:11 PM ET
Size
4.5 KB